The plight of the ‘asthmatic patient’ in South Africa – a subgroup analysis of the SABINA III study
Article Sidebar
Main Article Content
Abstract
-
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Kroegel C. Global Initiative for Asthma (GINA) guidelines: 15 years of application. Expert Rev Clin Immunol 2009;5(3):239-249. https://doi.org/10.1586/eci.09.1
GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990 - 2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 2017;5(9):691. https://doi.org/10.1016/S2213-2600(17)30293-X
Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma Programme. The global burden of asthma: Executive summary of the GINA Dissemination Committee report. Allergy 2004;59(5):469-478. https://doi.org/10.1111/j.1398- 9995.2004.00526.x
Pearce N, Aït-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma symptoms: Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007;62(9):758-766. https://doi.org/10.1136/ thx.2006.070169
Cazzoletti L, Marcon A, Corsico A, et al. Asthma severity according to Global Initiative for Asthma and its determinants: An international study. Int Arch Allergy Immunol 2010;151(1):70-79. https://doi.org/10.1159/000232572
Coumou H, Westerhof GA, De Nijs SB, Zwinderman AH, Bel EH. Predictors of accelerated decline in lung function in adult-onset asthma. Eur Respi J 2018;51(2):1701785. https://doi.org/10.1183/13993003.01785-2017
Bateman ED, Reddel HK, O’Byrne PM, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. New Eng J Med 2018;378(20):1877- 1887. https://doi.org/10.1056/NEJMoa1715275
O’Byrne PM, Mejza F. Advances in the treatment of mild asthma: Recent evidence. Polish Arch Int Medi 2018;128(9):545-549. https://doi.org/10.20452/pamw.4341
O’Byrne PM, FitzGerald JM, Bateman ED, et al. Inhaled combined budesonide- formoterol as needed in mild asthma. New Eng J Med 2018;378(20):1865-1876. https://doi.org/10.1056/NEJMoa1715274
Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short- acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme. Eur Respir J 2020;55(4):1901872. https://doi.org/10.1183%2F13993003.01872-2019
Bloom CI, Cabrera C, Arnetorp S, et al. Asthma-related health outcomes associated with short-acting β2-agonist inhaler use: An observational UK study as part of the SABINA Global Program. Adv Ther 2020;37(10):4190-4208.
Braido F, Brusselle G, Guastalla D, et al. Determinants and impact of suboptimal asthma control in Europe: The International Cross-Sectional and Longitudinal Assessment on Asthma Control (LIAISON) study. Respir Res 2016;17(1):1-10.
Gillissen A. Patients’ adherence in asthma. J Physiology Pharmacol 2007;58(5):205-222. 14. Lalloo U, Kalla I, Abdool-Gaffar S, et al. Guidelines for the management of asthma in adults and adolescents: Position statement of the South African Thoracic Society – 2021 update. Afr J Thoracic Crit Care Med 2021;27(4):30-43. https://doi.org/10.7196/AJTCCM.2021.v27i4.189